Drägerwerk AG & Co. KGaA

LSE:0MT8.LHealthcare

——At close · Market cap — · Next earnings Thu 29 Oct

EUR billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Revenue	3.4	3.3	3.0	3.4	3.4	3.5	+3.3%
Cost of revenue	1.8	1.9	1.9	2.0	1.9	2.0	+5.8%
Gross profit	1.6	1.5	1.2	1.4	1.4	1.5	+5.8%
Research & development	0.3	0.3	0.3	0.3	0.3	0.3	−4.1%
Selling, general & administrative	0.9	0.9	1.0	1.0	1.0	1.0	−6.0%
Selling & marketing	0.7	0.7	0.7	0.7	0.7	0.0	−100.0%
Operating expenses	1.1	1.2	1.2	1.2	1.3	1.3	−5.2%
Operating income	0.4	0.3	(0.1)	0.2	0.2	0.2	+44.5%
Interest expense	0.0	0.0	0.0	0.0	0.0	0.0	−3.1%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	+19.6%
Other income / expense	(0.1)	(0.0)	(0.0)	(0.0)	0.0	(0.0)	−314.5%
Pre-tax income	0.4	0.2	(0.1)	0.1	0.2	0.2	+22.9%
Income tax	0.1	0.1	(0.0)	0.0	0.1	0.1	+48.7%
Net income	0.2	0.1	(0.1)	0.1	0.1	0.1	+11.8%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—
Other net income adjustments	(0.1)	(0.0)	(0.0)	(0.0)	0.1	0.0	−100.0%
EPS, basic (per share)	10.22	7.16	(3.44)	5.89	6.65	7.44	+11.9%
EPS, diluted (per share)	10.22	7.16	(3.44)	5.89	6.65	7.44	+11.9%
EBITDA	0.5	0.4	0.1	0.3	0.2	0.4	+98.4%
Depreciation & amortization	0.1	0.1	0.1	0.1	0.1	0.1	+77.6%
Weighted average shares (shares)	18,453,151	18,760,000	18,760,000	18,760,000	18,760,147	18,737,979	−0.1%
Weighted average diluted shares (shares)	18,453,151	18,760,000	18,760,000	18,760,000	18,760,147	18,737,979	−0.1%
Gross margin	45.7%	44.4%	38.5%	41.6%	42.5%	43.5%	+1.0 pts
Operating margin	12.3%	8.5%	−2.4%	5.1%	4.9%	6.8%	+2.0 pts
Net margin	5.5%	4.0%	−2.1%	3.3%	3.7%	4.0%	+0.3 pts

EUR billionsUpdated Tue 31 Mar ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.